10% Owner of Cti Biopharma Corp (NASDAQ:CTIC), Orbimed Advisors Llc, sells 2,000,000 shares worth $7,000,000

According to Cti Biopharma Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 04:46 PM, company 10% Owner, Orbimed Advisors Llc disclosed selling 2,000,000 shares at a cost of $3.50. At the time of this transaction (Jan 07), this trade was worth $7,000,000 in total. As of Jan 07, Orbimed Advisors Llc now owns 7,520,600 shares in total worth about $25,946,070.0.

For the last few recent trades made by Cti Biopharma Corp (NASDAQ:CTIC) 10% Owner, Orbimed Advisors Llc, we have the following information:

Posted by George Daniels on Monday January 11 2021, 9:17 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0